News
Nuvalent buy delivers new cancer approval for GSK
GSK has its first approval from the $10.6bn takeover of Nuvalent, ROS1+ NSCLC therapy Jideytro, which becomes the company's first lung cancer product.
News
As patents expire, fampridine is cleared for NHS use in MS
Several years after other UK nations, people living with multiple sclerosis in England are finally able to get NHS treatment with fampridine.
News
Takeda gets first OK for orexin narcolepsy drug, in China
China has become the first country to approve Takeda's first-in-class orexin agonist, oveporexton, for the sleep disorder narcolepsy.
News
Trump sets course for 100%, then 200%, tariffs on generics
Trump has said he intends to impose tariffs of 100% on generic drugs imported into the US from 2028, rising to 200% after a year, in a reshoring push.
News
MSD gets first FDA okay for oral PCSK9 cholesterol drug
MSD has won the race to bring an oral PCSK9 inhibitor through to regulatory approval for LDL cholesterol-lowering in the US.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
